News 2023-06-23
Porton Pharma Solutions Welcomes Alexandra Pichard Nielsen, VP of Business Development, at BOS Basel 2023, Driving Innovation and Growth in the Pharmaceutical Industry
We’re honored to have Alexandra Pichard Nielsen, Vice President for Business Development at Porton Pharma Solutions Ltd., join us at BOS Basel 2023!
We are excited to witness Alexandra’s expertise and leadership in action as she explores new opportunities, fosters partnerships, and drives business growth for Porton Pharma.
Stay tuned for insightful updates on how Alexandra is spearheading our company’s expansion and shaping the future of the pharmaceutical industry.
Drop by our booth at Stand 17 if you want to catch up with Alexandra!
If you would like to preschedule a meeting, https://lnkd.in/eFzuWJBN
Others
More
News 2025-07-31
Porton Participates in Publishing an OPRD Paper, Demonstrating Strength in Drug Synthesis Technology
Metal catalytic and DoE technologies for the optimization of CT1812 synthesis routes
News 2025-07-31
NMPA Approves Jike Shu (Sebaloxavir Marboxil Tablets) for the Treatment of Uncomplicated Influenza in Adults
Self-developed novel PA endonuclease inhibitor anti-influenza drug Jike Shu (Sebaloxavir Marboxil Tablets) has officially received marketing approval from China's National Medical Products Administration (NMPA) for the treatment of uncomplicated influenza in adults.
